Tissue dendritic cells as portals for HIV entry

Reviews in Medical Virology

Volumn 23, Issue 5, 2013, Pages 319-333

  Harman, Andrew N ^a   Kim, Min ^a   Nasr, Najla ^a   Sandgren, Kerrie J ^a   Cameron, Paul U ^b  

^a WESTMEAD HOSPITAL   (Australia)

^b BURNET INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LECTIN RECEPTOR; TENOFOVIR;

ANAL INTERCOURSE; CD4+ T LYMPHOCYTE; COLUMNAR EPITHELIUM; DENDRITIC CELL; DERMIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LAMINA PROPRIA; NONHUMAN; PATHOLOGICAL ANATOMY; PROTEIN BINDING; REVIEW; SQUAMOUS EPITHELIUM; TARGET CELL; VIRUS ENTRY; VIRUS TRANSMISSION;

EID: 84882579669     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.1753     Document Type: Review

References (151)

1. Jolles S. Paul Langerhans. Journal of Clinical Pathology 2002; 55: 243.
2. Silberberg I. Apposition of mononuclear cells to Langerhans cells in contact allergic reactions. An ultrastructural study. Acta Dermato-Venereologica 1973; 53: 1-12.
3. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. The Journal of Experimental Medicine 1973; 137: 1142-1162.
4. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. The Journal of Experimental Medicine 1974; 139: 380-397.
5. Steinman RM, Lustig DS, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. 3. Functional properties in vivo. The Journal of Experimental Medicine 1974; 139: 1431-1445.
6. Iijima N, Thompson JM, Iwasaki A. Dendritic cells and macrophages in the genitourinary tract. Mucosal Immunology 2008; 1: 451-459. DOI: 10.1038/mi.2008.57
7. Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001; 106: 255-258. DOI: S0092-8674(01)00449-4 [pii]
8. Schuler G, Steinman RM. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. The Journal of Experimental Medicine 1985; 161: 526-546.
9. Inaba K, Young JW, Steinman RM. Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells. The Journal of Experimental Medicine 1987; 166: 182-194.
10. Steinman RM, Koide S, Witmer M, et al. The sensitization phase of T-cell-mediated immunity. Annals of the New York Academy of Sciences 1988; 546: 80-90.
11. Heufler C, Topar G, Koch F, et al. Cytokine gene expression in murine epidermal cell suspensions: interleukin 1 beta and macrophage inflammatory protein 1 alpha are selectively expressed in Langerhans cells but are differentially regulated in culture. The Journal of Experimental Medicine 1992; 176: 1221-1226.
12. Greter M, Lelios I, Pelczar P, et al. Stroma-derived interleukin-34 controls the development and maintenance of Langerhans cells and the maintenance of microglia. Immunity 2012; 37: 1050-1060. DOI: 10.1016/j.immuni.2012.11.001
13. Nagao K, Kobayashi T, Moro K, et al. Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin. Nature Immunology 2012; 13: 744-752. DOI: 10.1038/ni.2353
14. Wang S, Villablanca EJ, De Calisto J, et al. MyD88-dependent TLR1/2 signals educate dendritic cells with gut-specific imprinting properties. Journal of Immunology 2011; 187: 141-150. DOI: 10.4049/jimmunol.1003740
15. Mannon P, Reinisch W. Interleukin 13 and its role in gut defence and inflammation. Gut 2012; 61: 1765-1773. DOI: 10.1136/gutjnl-2012-303461
16. McDole JR, Wheeler LW, McDonald KG, et al. Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature 2012; 483: 345-349. DOI: 10.1038/nature10863
17. Miller CJ, Li Q, Abel K, et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. Journal of Virology 2005; 79: 9217-9227. DOI: 79/14/9217 [pii] 10.1128/JVI.79.14.9217-9227.2005
18. Lai SK, Hida K, Shukair S, et al. Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. Journal of Virology 2009; 83: 11196-11200. DOI: 10.1128/JVI.01899-08
19. Marx PA, Spira AI, Gettie A, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nature Medicine 1996; 2: 1084-1089.
20. Smith SM, Mefford M, Sodora D, et al. Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. AIDS 2004; 18: 1637-1643.
21. Pudney J, Quayle AJ, Anderson DJ. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biology of Reproduction 2005; 73: 1253-1263. DOI: 10.1095/biolreprod.105.043133
22. Lee HK, Zamora M, Linehan MM, et al. Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection. The Journal of Experimental Medicine 2009; 206: 359-370. DOI: 10.1084/jem.20080601
23. Maher D, Wu X, Schacker T, Horbul J, Southern P. HIV binding, penetration, and primary infection in human cervicovaginal tissue. Proceedings of the National Academy of Sciences of the United States of America 2005; 102: 11504-11509. DOI: 10.1073/pnas.0500848102
24. Hladik F, Sakchalathorn P, Ballweber L, et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 2007; 26: 257-270. DOI: 10.1016/j.immuni.2007.01.007
25. Keele BF, Estes JD. Barriers to mucosal transmission of immunodeficiency viruses. Blood 2011; 118: 839-846. DOI: 10.1182/blood-2010-12-325860
26. Ganor Y, Bomsel M. HIV-1 transmission in the male genital tract. American Journal of Reproductive Immunology 2010. DOI: 10.1111/j.1600-0897.2010.00933.x
27. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Medicine 2005; 2: e298. DOI: 10.1371/journal.pmed.0020298
28. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369: 643-656. DOI: 10.1016/S0140-6736(07)60312-2
29. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369: 657-666. DOI: 10.1016/S0140-6736(07)60313-4
30. Fischetti L, Barry SM, Hope TJ, Shattock RJ. HIV-1 infection of human penile explant tissue and protection by candidate microbicides. AIDS 2009; 23: 319-328. DOI: 10.1097/QAD.0b013e328321b778
31. Patterson BK, Landay A, Andersson J, et al. Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. American Journal of Pathology 1998; 153: 481-490. DOI: 10.1016/S0002-9440(10)65591-5
32. Ganor Y, Bomsel M. HIV-1 transmission in the male genital tract. American Journal of Reproductive Immunology 2011; 65: 284-291. DOI: 10.1111/j.1600-0897.2010.00933.x
33. Ganor Y, Zhou Z, Tudor D, et al. Within 1h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates. Mucosal Immunology 2010; 3: 506-522. DOI: 10.1038/mi.2010.32
34. Dinh MH, Hirbod T, Kigozi G, et al. No difference in keratin thickness between inner and outer foreskins from elective male circumcisions in Rakai, Uganda. PLoS One 2012; 7: e41271. DOI: 10.1371/journal.pone.0041271
35. Mehta SD, Green SJ, Maclean I, et al. Microbial diversity of genital ulcer disease in men enrolled in a randomized trial of male circumcision in Kisumu, Kenya. PLoS One 2012; 7: e38991. DOI: 10.1371/journal.pone.0038991
36. Cohen CR, Lingappa JR, Baeten JM, et al. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Medicine 2012; 9: e1001251. DOI: 10.1371/journal.pmed.1001251
37. Price LB, Liu CM, Johnson KE, et al. The effects of circumcision on the penis microbiome. PLoS One 2010; 5: e8422. DOI: 10.1371/journal.pone.0008422
38. Powers KA, Poole C, Pettifor AE, Cohen MS. Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. The Lancet Infectious Diseases 2008; 8: 553-563. DOI: 10.1016/S1473-3099(08)70156-7
39. Van Kemseke C. Sexually transmitted diseases and anorectum. Acta Gastroenterologica Belgica 2009; 72: 413-419.
40. Ribeiro Dos Santos P, Rancez M, Pretet JL, et al. Rapid dissemination of SIV follows multisite entry after rectal inoculation. PLoS One 2011; 6: e19493. DOI: 10.1371/journal.pone.0019493
41. Wang X, Rasmussen T, Pahar B, et al. Massive infection and loss of CD4+ T cells occurs in the intestinal tract of neonatal rhesus macaques in acute SIV infection. Blood 2007; 109: 1174-1181. DOI: 10.1182/blood-2006-04-015172
42. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005; 434: 1093-1097. DOI: 10.1038/nature03501
43. Schneider T, Jahn HU, Schmidt W, Riecken EO, Zeitz M, Ullrich R. Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin diarrhea/wasting syndrome study group. Gut 1995; 37: 524-529.
44. Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010; 116: e74-80. DOI: 10.1182/blood-2010-02-258558 [pii]
45. Cros J, Cagnard N, Woollard K, et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010; 33: 375-386. DOI: 10.1016/j.immuni.2010.08.012, [pii]: S1074-7613(10)00317-1
46. MacDonald KP, Munster DJ, Clark GJ, Dzionek A, Schmitz J, Hart DN. Characterization of human blood dendritic cell subsets. Blood 2002; 100: 4512-4520. DOI: 10.1182/blood-2001-11-0097 [pii]
47. Schakel K, von Kietzell M, Hansel A, et al. Human 6-sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes. Immunity 2006; 24: 767-777. DOI: 10.1016/j.immuni.2006.03.020, [pii]: S1074-7613(06)00231-7
48. Chu CC, Ali N, Karagiannis P, et al. Resident CD141 (BDCA3)+dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. The Journal of Experimental Medicine 2012; 209: 935-945. DOI: 10.1084/jem.20112583
49. Haniffa M, Shin A, Bigley V, et al. Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity 2012; 37: 60-73. DOI: 10.1016/j.immuni.2012.04.012
50. Lenz A, Heine M, Schuler G, Romani N. Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. The Journal of Clinical Investigation 1993; 92: 2587-2596. DOI: 10.1172/JCI116873
51. Harman AN, Bye CR, Nasr N, et al. Identification of lineage relationships and novel markers of blood and skin human dendritic cells. Journal of Immunology 2013; 190: 66-79. DOI: 10.4049/jimmunol.1200779
52. Romani N, Clausen BE, Stoitzner P. Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunological Reviews 2010; 234: 120-141. DOI: 10.1111/j.0105-2896.2009.00886.x
53. Gurney KB, Elliott J, Nassanian H, et al. Binding and transfer of human immunodeficiency virus by DC-SIGN+cells in human rectal mucosa. Journal of Virology 2005; 79: 5762-5773. DOI: 10.1128/JVI.79.9.5762-5773.2005
54. Prakash M, Kapembwa MS, Gotch F, Patterson S. Chemokine receptor expression on mucosal dendritic cells from the endocervix of healthy women. Journal of Infectious Diseases 2004; 190: 246-250. DOI: 10.1086/422034
55. Iijima N, Mattei LM, Iwasaki A. Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue. Proceedings of the National Academy of Sciences of the United States of America 2011; 108: 284-289. DOI: 10.1073/pnas.1005201108
56. Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood. The Journal of Experimental Medicine 1994; 180: 83-93.
57. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. The Journal of Experimental Medicine 1994; 179: 1109-1118.
58. Chaipan C, Soilleux EJ, Simpson P, et al. DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets. Journal of Virology 2006; 80: 8951-8960. DOI: 10.1128/JVI.00136-06
59. Lambert AA, Gilbert C, Richard M, Beaulieu AD, Tremblay MJ. The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways. Blood 2008; 112: 1299-1307. DOI: 10.1182/blood-2008-01-136473
60. Lambert AA, Barabe F, Gilbert C, Tremblay MJ. DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway. Blood 2011; 117: 6589-6599. DOI: 10.1182/blood-2011-01-331363
61. Geijtenbeek TB, Kwon DS, Torensma R, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000; 100: 587-597.
62. Geijtenbeek TB, Torensma R, van Vliet SJ, et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000; 100: 575-585.
63. Xu L, Li Q, Ye H, et al. The nine-repeat DC-SIGNR isoform is associated with increased HIV-RNA loads and HIV sexual transmission. Journal of Clinical Immunology 2010; 30: 402-407. DOI: 10.1007/s10875-010-9376-7
64. Turville SG, Cameron PU, Handley A, et al. Diversity of receptors binding HIV on dendritic cell subsets. Nature Immunology 2002; 3: 975-983. DOI: 10.1038/ni841, [pii]: ni841
65. de Witte L, Nabatov A, Pion M, et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nature Medicine 2007; 13: 367-371. DOI: 10.1038/nm1541, [pii]: nm1541
66. Martinelli E, Cicala C, Van Ryk D, et al. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 2007; 104: 3396-3401. DOI: 10.1073/pnas.0611353104
67. Lai J, Bernhard OK, Turville SG, Harman AN, Wilkinson J, Cunningham AL. Oligomerization of the macrophage mannose receptor enhances gp120-mediated binding of HIV-1. Journal of Biological Chemistry 2009; 284: 11027-11038. DOI: 10.1074/jbc.M809698200
68. Bozzacco L, Trumpfheller C, Siegal FP, et al. DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proceedings of the National Academy of Sciences of the United States of America 2007; 104: 1289-1294. DOI: 10.1073/pnas.0610383104
69. Hatsukari I, Singh P, Hitosugi N, et al. DEC-205-mediated internalization of HIV-1 results in the establishment of silent infection in renal tubular cells. Journal of the American Society of Nephrology 2007; 18: 780-787. DOI: 10.1681/ASN.2006121307
70. Sandgren KJ, Smed-Sorensen A, Forsell MN, et al. Human plasmacytoid dendritic cells efficiently capture HIV-1 envelope glycoproteins via CD4 for antigen presentation. Journal of Immunology 2013. DOI: 10.4049/jimmunol.1202489
71. de Witte L, Nabatov A, Geijtenbeek TB. Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission. Trends in Molecular Medicine 2008; 14: 12-19. DOI: 10.1016/j.molmed.2007.11.001
72. Schwartz AJ, Alvarez X, Lackner AA. Distribution and immunophenotype of DC-SIGN-expressing cells in SIV-infected and uninfected macaques. AIDS Research and Human Retroviruses 2002; 18: 1021-1029. DOI: 10.1089/08892220260235380
73. Huysamen C, Willment JA, Dennehy KM, Brown GD. CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes. Journal of Biological Chemistry 2008; 283: 16693-16701. DOI: 10.1074/jbc.M709923200
74. Celum C, Baeten JM. Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence. Current Opinion in Infectious Diseases 2012; 25: 51-57. DOI: 10.1097/QCO.0b013e32834ef5ef
75. Burton DR, Hessell AJ, Keele BF, et al. Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody. Proceedings of the National Academy of Sciences of the United States of America 2011; 108: 11181-11186. DOI: 10.1073/pnas.1103012108
76. Turville SG, Santos JJ, Frank I, et al. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 2004; 103: 2170-2179. DOI: 10.1182/blood-2003-09-3129
77. Coleman CM, Gelais CS, Wu L. Cellular and viral mechanisms of HIV-1 transmission mediated by dendritic cells. Advances in Experimental Medicine and Biology 2013; 762: 109-130. DOI: 10.1007/978-1-4614-4433-6_4
78. Garcia E, Pion M, Pelchen-Matthews A, et al. HIV-1 trafficking to the dendritic cell-T-cell infectious synapse uses a pathway of tetraspanin sorting to the immunological synapse. Traffic 2005; 6: 488-501. DOI: 10.1111/j.1600-0854.2005.00293.x, [pii]: TRA293
79. Yu HJ, Reuter MA, McDonald D. HIV traffics through a specialized, surface-accessible intracellular compartment during trans-infection of T cells by mature dendritic cells. PLoS Pathogens 2008; 4: e1000134. DOI: 10.1371/journal.ppat.1000134
80. Harbison CE, Lyi SM, Weichert WS, Parrish CR. Early steps in cell infection by parvoviruses: host-specific differences in cell receptor binding but similar endosomal trafficking. Journal of Virology 2009; 83: 10504-10514. DOI: 10.1128/JVI.00295-09
81. Garcia E, Nikolic DS, Piguet V. HIV-1 replication in dendritic cells occurs through a tetraspanin-containing compartment enriched in AP-3. Traffic 2008; 9: 200-214. DOI: 10.1111/j.1600-0854.2007.00678.x
82. Frank I, Piatak M Jr., Stoessel H, et al. Infectious and whole inactivated simian immunodeficiency viruses interact similarly with primate dendritic cells (DCs): differential intracellular fate of virions in mature and immature DCs. Journal of Virology 2002; 76: 2936-2951.
83. Miyauchi K, Kim Y, Latinovic O, Morozov V, Melikyan GB. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 2009; 137: 433-444. DOI: 10.1016/j.cell.2009.02.046
84. Fonteneau JF, Kavanagh DG, Lirvall M, et al. Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. Blood 2003; 102: 4448-4455. DOI: 10.1182/blood-2003-06-1801
85. Larsson M, Fonteneau JF, Lirvall M, Haslett P, Lifson JD, Bhardwaj N. Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells: roles for cross-presentation and non-infectious HIV-1 virus. AIDS 2002; 16: 1319-1329.
86. Moris A, Pajot A, Blanchet F, Guivel-Benhassine F, Salcedo M, Schwartz O. Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer. Blood 2006; 108: 1643-1651. DOI: 10.1182/blood-2006-02-006361
87. Turville SG, Aravantinou M, Stossel H, Romani N, Robbiani M. Resolution of de novo HIV production and trafficking in immature dendritic cells. Nature Methods 2008; 5: 75-85. DOI: 10.1038/nmeth1137
88. Harman AN, Kraus M, Bye CR, et al. HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase. Blood 2009; 114: 85-94. DOI: 10.1182/blood-2008-12-194845 [pii]: blood-2008-12-194845
89. Papatriantafyllou M. Inflammation: Under the skin. Nature Reviews Immunology 2011; 11: 800. DOI: 10.1038/nri3113
90. Rescigno M, Urbano M, Valzasina B, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nature Immunology 2001; 2: 361-367. DOI: 10.1038/86373
91. Cavarelli M, Foglieni C, Rescigno M, Scarlatti G. R5 HIV-1 envelope attracts dendritic cells to cross the human intestinal epithelium and sample luminal virions via engagement of the CCR5. EMBO Molecular Medicine 2013. DOI: 10.1002/emmm.201202232
92. Cunningham AL, Harman A, Nasr N. Initial HIV mucosal infection and dendritic cells. EMBO Molecular Medicine 2013; 5: 658-660. DOI: 10.1002/emmm.201202763
93. Cimarelli A, Zambruno G, Marconi A, Girolomoni G, Bertazzoni U, Giannetti A. Quantitation by competitive PCR of HIV-1 proviral DNA in epidermal Langerhans cells of HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes 1994; 7: 230-235.
94. Dezutter-Dambuyant C. In vivo and in vitro infection of human Langerhans cells by HIV-1. Advances in Experimental Medicine and Biology 1995; 378: 447-451.
95. Giannetti A, Zambruno G, Cimarelli A, et al. Direct detection of HIV-1 RNA in epidermal Langerhans cells of HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes 1993; 6: 329-333.
96. Henry M, Uthman A, Ballaun C, Stingl G, Tschachler E. Epidermal Langerhans cells of AIDS patients express HIV-1 regulatory and structural genes. The Journal of Investigative Dermatology 1994; 103: 593-596.
97. Compton CC, Kupper TS, Nadire KB. HIV-infected Langerhans cells constitute a significant proportion of the epidermal Langerhans cell population throughout the course of HIV disease. The Journal of Investigative Dermatology 1996; 107: 822-826.
98. Berger R, Gartner S, Rappersberger K, Foster CA, Wolff K, Stingl G. Isolation of human immunodeficiency virus type 1 from human epidermis: virus replication and transmission studies. The Journal of Investigative Dermatology 1992; 99: 271-277.
99. Ayehunie S, Groves RW, Bruzzese AM, Ruprecht RM, Kupper TS, Langhoff E. Acutely infected Langerhans cells are more efficient than T cells in disseminating HIV type 1 to activated T cells following a short cell-cell contact. AIDS Research and Human Retroviruses 1995; 11: 877-884.
100. Pope M, Betjes MG, Romani N, et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 1994; 78: 389-398.
101. Kawamura T, Gulden FO, Sugaya M, et al. R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms. Proceedings of the National Academy of Sciences of the United States of America 2003; 100: 8401-8406. DOI: 10.1073/pnas.1432450100
102. Zaitseva M, Blauvelt A, Lee S, et al. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nature Medicine 1997; 3: 1369-1375.
103. de Jong MA, de Witte L, Oudhoff MJ, Gringhuis SI, Gallay P, Geijtenbeek TB. TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo. The Journal of Clinical Investigation 2008; 118: 3440-3452. DOI: 10.1172/JCI34721
104. de Jong MA, de Witte L, Taylor ME, Geijtenbeek TB. Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function. Journal of Immunology 2010; 185: 1633-1641. DOI: 10.4049/jimmunol.0904137
105. Sivard P, Berlier W, Picard B, Sabido O, Genin C, Misery L. HIV-1 infection of Langerhans cells in a reconstructed vaginal mucosa. Journal of Infectious Diseases 2004; 190: 227-235. DOI: 10.1086/421704
106. Kawamura T, Bruse SE, Abraha A, et al. PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes. Journal of Virology 2004; 78: 7602-7609. DOI: 10.1128/JVI.78.14.7602-7609.2004
107. Sugaya M, Lore K, Koup RA, Douek DC, Blauvelt A. HIV-infected Langerhans cells preferentially transmit virus to proliferating autologous CD4+ memory T cells located within Langerhans cell-T cell clusters. Journal of Immunology 2004; 172: 2219-2224.
108. Sugaya M, Hartley O, Root MJ, Blauvelt A. C34, a membrane fusion inhibitor, blocks HIV infection of Langerhans cells and viral transmission to T cells. The Journal of Investigative Dermatology 2007; 127: 1436-1443. DOI: 10.1038/sj.jid.5700736
109. Blauvelt A, Asada H, Saville MW, et al. Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways. The Journal of Clinical Investigation 1997; 100: 2043-2053. DOI: 10.1172/JCI119737
110. Lynch GW, Slaytor EK, Elliott FD, et al. CD4 is expressed by epidermal Langerhans' cells predominantly as covalent dimers. Experimental Dermatology 2003; 12: 700-711.
111. Chen HY, Di Mascio M, Perelson AS, Ho DD, Zhang L. Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques. Proceedings of the National Academy of Sciences of the United States of America 2007; 104: 19079-19084. DOI: 10.1073/pnas.0707449104 [pii]
112. Dimitrov DS, Willey RL, Sato H, Chang LJ, Blumenthal R, Martin MA. Quantitation of human immunodeficiency virus type 1 infection kinetics. Journal of Virology 1993; 67: 2182-2190.
113. Meng G, Wei X, Wu X, et al. Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nature Medicine 2002; 8: 150-156. DOI: 10.1038/nm0202-150
114. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. Journal of Infectious Diseases 2002; 185: 45-52. DOI: 10.1086/338231
115. Zhu J, Hladik F, Woodward A, et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nature Medicine 2009; 15: 886-892. DOI: 10.1038/nm.2006
116. Kawamura T, Koyanagi Y, Nakamura Y, et al. Significant virus replication in Langerhans cells following application of HIV to abraded skin: relevance to occupational transmission of HIV. Journal of Immunology 2008; 180: 3297-3304.
117. Santegoets SJ, Gibbs S, Kroeze K, et al. Transcriptional profiling of human skin-resident Langerhans cells and CD1a+dermal dendritic cells: differential activation states suggest distinct functions. Journal of Leukocyte Biology 2008; 84: 143-151. DOI: 10.1189/jlb.1107750
118. Kwan WH, Helt AM, Maranon C, et al. Dendritic cell precursors are permissive to dengue virus and human immunodeficiency virus infection. Journal of Virology 2005; 79: 7291-7299. DOI: 10.1128/JVI.79.12.7291-7299.2005
119. McElrath M, Smythe K, Randolph-Habecker J, et al. Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anus. Journal of Acquired Immune Deficiency Syndromes 2013. DOI: 10.1097/QAI.0b013e3182898392
120. Shen R, Smythies LE, Clements RH, Novak L, Smith PD. Dendritic cells transmit HIV-1 through human small intestinal mucosa. Journal of Leukocyte Biology 2010; 87: 663-670. DOI: 10.1189/jlb.0909605
121. Harman AN, Wilkinson J, Bye CR, et al. HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells. Journal of Immunology 2006; 177: 7103-7113. DOI: 177/10/7103 [pii]
122. Fantuzzi L, Purificato C, Donato K, Belardelli F, Gessani S. Human immunodeficiency virus type 1 gp120 induces abnormal maturation and functional alterations of dendritic cells: a novel mechanism for AIDS pathogenesis. Journal of Virology 2004; 78: 9763-9772. DOI: 10.1128/JVI.78.18.9763-9772.2004
123. Wilflingseder D, Mullauer B, Schramek H, et al. HIV-1-induced migration of monocyte-derived dendritic cells is associated with differential activation of MAPK pathways. Journal of Immunology 2004; 173: 7497-7505.
124. Granelli-Piperno A, Golebiowska A, Trumpfheller C, Siegal FP, Steinman RM. HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proceedings of the National Academy of Sciences of the United States of America 2004; 101: 7669-7674. DOI: 10.1073/pnas.0402431101
125. Smed-Sorensen A, Lore K, Walther-Jallow L, Andersson J, Spetz AL. HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation. Blood 2004; 104: 2810-2817. DOI: 10.1182/blood-2003-07-2314
126. Harman AN, Lai J, Turville S, et al. HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Blood 2011; 118: 298-308. DOI: 10.1182/blood-2010-07-297721
127. Nasr N, Maddocks S, Turville SG, et al. HIV-1 infection of human macrophages directly induces viperin which inhibits viral production. Blood 2012; 120: 778-788. DOI: 10.1182/blood-2012-01-407395
128. Doehle BP, Chang K, Rustagi A, McNevin J, McElrath MJ, Gale M Jr. Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism. Journal of Virology 2012; 86: 8367-8374. DOI: 10.1128/JVI.00423-12
129. Doehle BP, Hladik F, McNevin JP, McElrath MJ, Gale M Jr. Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. Journal of Virology 2009; 83: 10395-10405. DOI: 10.1128/JVI.00849-09 [pii]
130. Okumura A, Alce T, Lubyova B, Ezelle H, Strebel K, Pitha PM. HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 2008; 373: 85-97. DOI: 10.1016/j.virol.2007.10.042, [pii]: S0042-6822(07)00732-5
131. Berger G, Durand S, Fargier G, et al. APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. PLoS Pathogens 2011; 7: e1002221. DOI: 10.1371/journal.ppat.1002221
132. Laguette N, Rahm N, Sobhian B, et al. Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein. Cell Host & Microbe 2012; 11: 205-217. DOI: 10.1016/j.chom.2012.01.007
133. Mashiba M, Collins KL. Molecular mechanisms of HIV immune evasion of the innate immune response in myeloid cells. Viruses 2013; 5: 1-14.
134. Hirsch VM, Sharkey ME, Brown CR, et al. Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification. Nature Medicine 1998; 4: 1401-1408. DOI: 10.1038/3992
135. Belshan M, Kimata JT, Brown C, et al. Vpx is critical for SIVmne infection of pigtail macaques. Retrovirology 2012; 9: 32. DOI: 10.1186/1742-4690-9-32
136. Goldstone DC, Ennis-Adeniran V, Hedden JJ, et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 2011; 480: 379-382. DOI: 10.1038/nature10623
137. Lahouassa H, Daddacha W, Hofmann H, et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nature Immunology 2012; 13: 223-228. DOI: 10.1038/ni.2236
138. Hrecka K, Hao C, Gierszewska M, et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011; 474: 658-661. DOI: 10.1038/nature10195
139. Laguette N, Sobhian B, Casartelli N, et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011; 474: 654-657. DOI: 10.1038/nature10117
140. Cheong C, Choi JH, Vitale L, et al. Improved cellular and humoral immune responses in vivo following targeting of HIV gag to dendritic cells within human anti-human DEC205 monoclonal antibody. Blood 2010; 116: 3828-3838. DOI: 10.1182/blood-2010-06-288068
141. Flynn BJ, Kastenmuller K, Wille-Reece U, et al. Immunization with HIV gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates. Proceedings of the National Academy of Sciences of the United States of America 2011; 108: 7131-7136. DOI: 10.1073/pnas.1103869108
142. Nchinda G, Amadu D, Trumpfheller C, Mizenina O, Uberla K, Steinman RM. Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8+ T cells. Proceedings of the National Academy of Sciences of the United States of America 2010; 107: 4281-4286. DOI: 10.1073/pnas.1000621107
143. Frank I, Stossel H, Gettie A, et al. A fusion inhibitor prevents spread of immunodeficiency viruses, but not activation of virus-specific T cells, by dendritic cells. Journal of Virology 2008; 82: 5329-5339. DOI: 10.1128/JVI.01987-07
144. Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nature Medicine 1997; 3: 42-47.
145. Bomsel M, Heyman M, Hocini H, et al. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity 1998; 9: 277-287.
146. Alfsen A, Iniguez P, Bouguyon E, Bomsel M. Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1. Journal of Immunology 2001; 166: 6257-6265.
147. Alfsen A, Yu H, Magerus-Chatinet A, Schmitt A, Bomsel M. HIV-1-infected blood mononuclear cells form an integrin- and agrin-dependent viral synapse to induce efficient HIV-1 transcytosis across epithelial cell monolayer. Molecular Biology of the Cell 2005; 16: 4267-4279. DOI: 10.1091/mbc.E05-03-0192
148. Kaul R, Pettengell C, Sheth PM, et al. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission. Journal of Reproductive Immunology 2008; 77: 32-40. DOI: 10.1016/j.jri.2007.02.002
149. Hirbod T, Kaldensjo T, Broliden K. In situ distribution of HIV-binding CCR5 and C-type lectin receptors in the human endocervical mucosa. PLoS One 2011; 6: e25551. DOI: 10.1371/journal.pone.0025551
150. Couedel-Courteille A, Butor C, Juillard V, Guillet JG, Venet A. Dissemination of SIV after rectal infection preferentially involves paracolic germinal centers. Virology 1999; 260: 277-294. DOI: 10.1006/viro.1999.9809
151. Hu J, Gardner MB, Miller CJ. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. Journal of Virology 2000; 74: 6087-6095.